Salataz Side Effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
If there are any side effects, talk to the doctor, pharmacist or nurse. This includes any side effects not listed in this monograph.
The serious side effects of SALATAZ 4 g/0.5 g powder for solution for infusion are: swelling of the face, lips, tongue or other parts of the body; shortness of breath, wheezing or trouble breathing; severe rash, itching or hives on the skin; yellowing of the eyes or skin; damage to blood cells (the signs include: being breathless when not expecting it, red or brown urine, nose-bleeds and bruising).
If any of the previously mentioned is noticed, see a doctor straight away. For frequency of these reactions, refer to the following information.
Possible side effects are listed according to the following categories: Common: affects 1 to 10 users in 100; uncommon: affects 1 to 10 users in 1,000; rare: affects 1 to 10 users in 10,000; very rare: affects less than 1 user in 10,000.
Common side effects: diarrhoea, vomiting, nausea; skin rashes.
Uncommon side effects: thrush; (abnormal) decrease in white blood cells (leukopenia, neutropenia) and platelets (thrombocytopenia); allergic reaction; headache, sleeplessness; low blood pressure, inflammation of the veins (felt as tenderness or redness in the affected area); jaundice (yellow staining of the skin or whites of the eyes), inflammation of the mucous lining of the mouth, constipation, indigestion, stomach upset; increase of certain enzymes in the blood (alanine aminotransferase increased, aspartate aminotransferase increased); itching, nettle rash; increase of muscle metabolism product in the blood (blood creatinine increased); fever, injection site reaction; yeast infection (candidal superinfection).
Rare side effects: (abnormal) decrease of red blood cells or blood pigment / haemoglobin, (abnormal) decrease of red blood cells due to premature breakdown (degradation) (haemolytic anaemia), small spot bruising (purpura), bleeding of the nose (epistaxis) and bleeding time prolonged, (abnormal) increase of a specific type of white blood cells (eosinophilia); severe allergic reaction (anaphylactic/anaphylactoid reaction, including shock); flushed red skin; a certain form of infection of the colon (pseudomembranous colitis), abdominal pain; inflammation of the liver (hepatitis), increase of a blood pigments breakdown product (bilirubin), increase of certain enzymes in the blood (blood alkaline phosphatase increased, gamma-glutamyltransferase increased); skin reactions with redness and formation of skin lesions (exanthema, erythema multiforme), skin reactions with blistering (bullous dermatitis); joint and muscle pain; poor kidney functions and kidney problems; rigors chill / rigidity.
Very rare side effects: severe decrease of granular white blood cells (agranulocytosis), severe decrease of red blood cells, white blood cells and platelets (pancytopenia); prolonged time for blood clot formation (prolonged partial thromboplastin time, prothrombin time prolonged), abnormal lab test (positive direct Coombs), increase of platelets (thrombocythaemia); decrease of potassium in the blood (hypokalaemia), decrease of blood sugar (glucose), decrease of the blood protein albumin, decrease of blood total protein; detachment of the top layer of the skin all over the body (toxic epidermal necrolysis), serious bodywide allergic reaction with skin and mucous lining rashes and various skin eruptions (Stevens-Johnson Syndrome); blood urea nitrogen increased.
Piperacillin therapy has been associated with an increased incidence of fever and rash in cystic fibrosis patients.